The Vancouver company is developing three dissolvable cannabinoid products.
The post XPhyto Therapeutics Eyes Pivotal 2022 clinical trial for epilepsy with CBD strips appeared first on CannCentral.
The Vancouver company is developing three dissolvable cannabinoid products.
The post XPhyto Therapeutics Eyes Pivotal 2022 clinical trial for epilepsy with CBD strips appeared first on CannCentral.
Get updates delivered right to your inbox!